In vitro antimicrobial activity of Thai stick cannabis Hang Kra Rog Phu Phan (Cannabis sativa L.), sugar leaves extract against pathogenic bacteria
- PMID: 40568500
- PMCID: PMC12186785
- DOI: 10.5455/javar.2025.l870
In vitro antimicrobial activity of Thai stick cannabis Hang Kra Rog Phu Phan (Cannabis sativa L.), sugar leaves extract against pathogenic bacteria
Abstract
Objective: Cannabis sativa L. is aware of a rich source of bioactive substances with various structures that exhibit pharmacological activity in the central nervous system, cardiovascular, cerebrovascular, respiratory, reproductive, and gastrointestinal systems.
Materials and methods: In this study, cannabis sugar leaves were soaked in 99% ethanol, followed by evaporation. The antibacterial effect of the cannabis sugar leaf extract was then evaluated using the disc diffusion method. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) were determined using broth dilution.
Results: The results of this study indicated that the cannabis sugar leaf extract inhibited Bacillus cereus, Vibrio cholerae, Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis when compared to tetracycline, but it did not inhibit Pseudomonas aeruginosa. The MIC and MBC of the cannabis sugar leaves extract against B. cereus, V. cholerae, E. coli, S. aureus, and S. epidermidis were 0.977, 1.953, 31.25, 62.5, 125, 250, 250, 500, 250, and 500 mg/ml, respectively. The bioactive compounds in cannabis sugar leaf extract were identified using high-performance liquid chromatography.
Conclusion: The results indicated that the major bioactive compounds were Δ-9- tetrahydrocannabinol (THC) and cannabidiol (CBD). While minor bioactive compounds included gallic acid and tannic acid. These results support the benefits of cannabis sugar leaf extract, which has been used for its pharmacological properties and may be useful as an alternative antimicrobial agent in medicine.
Keywords: Cannabis sativa L.; antimicrobial activity; cannabidiol; gallic acid; tannic acid; Δ-9- tetrahydrocannabinol.
© The authors.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures




Similar articles
-
Evaluation of the Antibacterial Potential of Ethanolic Cannabis sativa L. (Hang Kra Rog Phu Phan ST1) Extracts Against Human Pathogenic Bacteria.Pak J Biol Sci. 2025 Jan;28(1):1-7. doi: 10.3923/pjbs.2025.1.7. Pak J Biol Sci. 2025. PMID: 39820562
-
Assessing the antibacterial potency of royal jelly: Minimum inhibitory concentration and minimum bactericidal concentration evaluation against Streptococcus mutans and Staphylococcus aureus.J Conserv Dent Endod. 2025 Jun;28(6):505-509. doi: 10.4103/JCDE.JCDE_682_24. Epub 2025 Jun 2. J Conserv Dent Endod. 2025. PMID: 40546856 Free PMC article.
-
In vitro antibacterial activity of Bersama abyssinica Fresen crude extract against representative Gram-positive and Gram-negative bacterial isolates.Vet Med Sci. 2024 Jul;10(4):e1498. doi: 10.1002/vms3.1498. Vet Med Sci. 2024. PMID: 38896065 Free PMC article.
-
Cannabis-based medicines for chronic neuropathic pain in adults.Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2. Cochrane Database Syst Rev. 2018. PMID: 29513392 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
References
-
- Thomas BF, ElSohly MA, Thomas BF, ElSohly MA. The analytical chemistry of Cannabis. Amsterdam, Netherlands: Elsevier; 2016. Chapter 1 - The botany of Cannabis sativa L; pp. 1–26. https://doi.org/10.1016/B978-0-12-804646-3.00001-1.
-
- Small E. Evolution and classification of Cannabis sativa (Marijuana, Hemp) in relation to human utilization. Bot Rev. 2015;81:189–294. https://doi.org/10.1007/s12229-015-9157-3.
-
- Alharbi YN. Current legal status of medical marijuana and cannabidiol in the United States. Epilepsy Behav. 2020;112:107452. https://doi.org/10.1016/j.yebeh.2020.107452. - PubMed
-
- Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Clinical and preclinical evidence for functional interactions of cannabidiol and Δ9-tetrahydrocannabinol. Neuropsychopharmacol. 2018;43:142–54. https://doi.org/10.1038/npp.2017.209. - PMC - PubMed
-
- Ahmed M, Ji M, Qin P, Gu Z, Liu Y, Sikandar A, et al. Phytochemical screening, total phenolic and flavonoids contents and antioxidant activities of Citrullus colocynthis L. and Cannabis sativa L. Appl Ecol Environ Res. 2019;17:3. https://doi.org/10.15666/aeer/1703_69616979.
LinkOut - more resources
Full Text Sources